List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 42 studies with search of: Fosamprenavir OR Lexiva[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 No longer available Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
2 Active, not recruiting A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Condition: HIV Infection
Interventions: Drug: fosamprenavir (GW433908);   Drug: ritonavir
3 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
4 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
5 Recruiting Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Condition: HIV Infection
Interventions: Drug: GW433908;   Drug: ritonavir
6 Completed Fosamprenavir Versus Other Protease Inhibitors
Condition: HIV Infection
Intervention: Drug: fosamprenavir
7 Completed
Has Results 		A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
Condition: HIV Infection
Interventions: Drug: Full Boosted Fosamprenavir;   Drug: Half-boosted Fosamprenavir
8 Recruiting 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
9 Completed A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Condition: HIV Infection
Interventions: Drug: ritonavir;   Drug: fosamprenavir
10 Recruiting Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Conditions: Hypertriglyceridemia;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
11 Terminated Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects
Condition: HIV-1
Interventions: Drug: fosamprenavir/ritonavir (700mg/100mg BID);   Drug: fosamprenavir/ritonavir (1400mg/100mg BID);   Drug: fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID)
12 Completed Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Condition: HIV Infections
Interventions: Drug: fosamprenavir;   Drug: COMBIVIR;   Drug: ritonavir;   Drug: TRIZIVIR
13 Completed Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
Condition: HIV Infection
Intervention: Drug: No intervention; Observational study
14 Not yet recruiting Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
15 Active, not recruiting "The Once A Day Protease Inhibitor Regimens"
Conditions: HIV Infections;   Antiretroviral Therapy
Interventions: Drug: ritonavir-boosted atazanavir;   Drug: ritonavir-boosted fosamprenavir
16 Completed
Has Results 		HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Condition: HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
17 Active, not recruiting Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
18 Completed Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate
19 Completed Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Nelfinavir;   Drug: Lopinavir/ritonavir;   Drug: Ritonavir;   Drug: Amprenavir;   Drug: Indinavir;   Drug: Saquinavir;   Drug: Fosamprenavir;   Drug: Atazanavir;   Drug: Tipranavir;   Drug: Dose adjustment
20 Recruiting Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: darunavir/ritonavir

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services